These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...
JPMorgan analyst Jessica Fye adjusted the price target for Ascendis Pharma (NASDAQ:ASND), a $7.74 billion biotech company, to $167.00, a slight increase from the previous $165.00, while reiterating ...
J.P. Morgan analyst Jessica Fye maintained a Buy rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $167.00.
In a report released on January 27, Jessica Fye from J.P. Morgan maintained a Buy rating on Intra-Cellular Therapies (ITCI – Research Report), ...
Jessica Alba and Cash Warren are splitting after 16 years of marriage — but they're vowing to "forever be family." Alba, 43, announced her separation from film producer Warren, 46, in a Thursday ...
Actor and the Honest Co. co-founder Jessica Alba has confirmed her split from her husband of 16 years, Pair of Thieves apparel co-founder Cash Warren. The “Dark Angel” and “L.A.’s Finest ...
Jessica Alba and Cash Warren have split after 16 years of marriage. On Thursday, the actress – who has recently been at the center of divorce rumors – took to social media to confirm the news ...
Jessica Alba is opening up about her separation from film producer Cash Warren, her husband of 16 years. Alba on Thursday said in a statement that she and Warren, who have been married since 2008 ...
I just wrapped up a productive week at the 2025 JP Morgan Healthcare Conference, where the world’s biopharma industry converges in San Francisco to find opportunities for dealmaking, advance ...
Jessica Alba has been keeping a low profile following ongoing rumors involving her marriage to Cash Warren, but on Wednesday, the Hollywood star stepped out for a very important reason. Like all ...
Jessica Alba is reportedly moving forward in her breakup with Cash Warren. The “Honey” actress, 43, has retained a divorce attorney after allegedly separating from her husband of 16 years ...
Jan 16 (Reuters) - J.P.Morgan estimated spending on data centers could contribute between 10-20 basis points to U.S. economic growth in 2025-2026 as technology companies race to benefit from the ...